GSK's shares were hit last week by investor concerns about the litigation around potential cancer-causing impurities that prompted the drug's withdrawal from markets in 2019 and 2020.
(Reporting by Leroy Leo in Bengaluru; Editing by Aditya Soni)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,734 GBX | +0.29% | +4.87% | +19.54% |
05-03 | GSK : DZ Bank remains Neutral | ZD |
05-03 | GSK plc : Back on track |
(Reuters) - GlaxoSmithKline Plc said on Tuesday that plaintiffs in the first scheduled U.S. lawsuit around heartburn drug Zantac will file a notice to voluntarily dismiss the case.
GSK's shares were hit last week by investor concerns about the litigation around potential cancer-causing impurities that prompted the drug's withdrawal from markets in 2019 and 2020.
(Reporting by Leroy Leo in Bengaluru; Editing by Aditya Soni)
1st Jan change | Capi. | |
---|---|---|
+19.54% | 88.72B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |